News Archive

FAU's Charles E. Schmidt College of Medicine recently hosted the summit, bringing together top scientists from North America and Europe to discuss the latest amyloid research and advancements.

A breakthrough by FAU researchers shows that blocking the kappa opioid receptor improves behavioral deficits tied to ADHD, autism and bipolar disorder, providing a potentially safer yet effective treatment.

FAU Jupiter’s Multi-institute Research Hub Hosts Joint Event to Celebrate Biomedical Research Driven by the Next Generation of Scientists

Stiles-Nicholson Brain Institute Marks Opening of Neurodegenerative Disease Research Center

Florida Atlantic University's Stiles-Nicholson Brain Institute will celebrate advancements in brain science and health with its annual "Brainy Days" events throughout the month of March.

FAU neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system.

FAU researchers have developed cutting-edge fluorescent cholesterol probes, which now enable them to visualize cholesterol movement and distribution in live cells with unprecedented detail.

Randy D. Blakely, Ph.D., a highly regarded neuroscientist and pharmacologist, is among an extraordinary group selected by the American Society for Pharmacology and Experimental Therapeutics.

FAU has added a new state-of-the-art MRI system to its research infrastructure, marking a transformative step forward for groundbreaking studies in neuroscience, clinical health and medical advancements.

A groundbreaking study by FAU researchers using a tiny roundworm, links the worm gene swip-10 to copper regulation, which could pave the way for new treatments for neurodegenerative disorders.